CAM
TEVA icon

Centre Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Centre Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-4,560
Closed -$284K – 108
2015
Q1 		$284K Hold
4,560
– – 0.04% 98
2014
Q4 		$262K Buy
+4,560
New +$254K 0.04% 107
2014
Q3 		– Sell
-17,440
Closed -$914K – 128
2014
Q2 		$914K Buy
+17,440
New +$891K 0.14% 82

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Centre Asset Management's TEVA Position: Q2 2015 in Review

Centre Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2015, closing a stake of 4,560 shares — an estimated $284K sold.

Centre Asset Management first reported a position in TEVA in Q2 2014 and held it in 3 quarters. The position peaked at $914K in Q2 2014. 818 funds tracked by Wall St. Rank hold TEVA as of Q2 2015.

  • Centre Asset Management reported no remaining Teva Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Centre Asset Management sold 4,560 Teva Pharmaceuticals shares in Q2 2015, an estimated $284K.
  • Centre Asset Management first reported a position in Teva Pharmaceuticals in Q2 2014 and held it in 3 quarters.
  • Centre Asset Management's Teva Pharmaceuticals position peaked at $914K in Q2 2014.
  • 818 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2015.

Based on Centre Asset Management's 13F filing for Q2 2015, filed 11 Aug 2015.